A yeast-based functional assay for the detection of the mutant androgen receptor in prostate cancer.

Publisher Website
Google Scholar
Abstract
Mutations in the ligand-binding domain of the human androgen receptor (AR) figure among the ways used by prostate adenocarcinoma (PCa) cells to escape androgen dependence. These mutations may broaden the specificity and/or affinity of the AR to other hormones, resulting in inappropriate receptor activation and thus affecting the PCa response to physiological stimuli and hormonal therapies.

This publication has 0 references indexed in Scilit: